Tagged with myalgic encephalomyelitis

Study suggests COVID-19 could be a potential trigger for ME/CFS.

Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.

Researchers discover drug Naltrexone restored function of faulty receptors associated with ME/CFS.

Chronic fatigue syndrome, or myalgic encephalomyelitis, is a highly debilitating, but often misunderstood, disorder, writes Professor Sonya Marshall-Gradisnik from the Griffith Health Institute.